131 related articles for article (PubMed ID: 19268183)
1. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Foreword].
Guelfi JD; Costentin J; Terra JL
Encephale; 2009 Jan; Suppl 3():S85-6. PubMed ID: 19268183
[No Abstract] [Full Text] [Related]
2. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Buis C; Gourion D; Vaiva G
Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
[No Abstract] [Full Text] [Related]
3. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
Canceil O; Limosin F; Passerieux C
Encephale; 2009 Jan; Suppl 3():S101-7. PubMed ID: 19268178
[No Abstract] [Full Text] [Related]
4. [Expert opinion on APAP (Prolonged action atypical antipsychotic agents). Conclusion].
Guelfi JD
Encephale; 2009 Jan; Suppl 3():S123-4. PubMed ID: 19268182
[No Abstract] [Full Text] [Related]
5. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of Canadian psychiatry].
Stip E
Encephale; 2009 Jan; Suppl 3():S115-8. PubMed ID: 19268180
[No Abstract] [Full Text] [Related]
6. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
Costentin J
Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
[No Abstract] [Full Text] [Related]
7. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
Dassa D; Lacambre M; Vacheron MN
Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
[No Abstract] [Full Text] [Related]
8. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
Chéreau I; Gorwood P; Mouchabac S
Encephale; 2009 Jan; Suppl 3():S97-100. PubMed ID: 19268186
[No Abstract] [Full Text] [Related]
9. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
Benoit M; Pon J; Zimmermann MA
Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
[No Abstract] [Full Text] [Related]
10. Psychopharmacological treatment of schizophrenia.
Lehmann HE
Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851
[No Abstract] [Full Text] [Related]
11. Is depot medication safe in the setting of myopathy?
Price JR; Bastiampillai T; Dhillon RS
Aust N Z J Psychiatry; 2009 Aug; 43(8):781-3. PubMed ID: 19629801
[No Abstract] [Full Text] [Related]
12. [Cost analysis of the strategies in the treatment of schizophrenics: the place of sustained release injectable atypical antipsychotics].
Gasquet I; Bouhassira M; Launois R
Encephale; 2005; 31(4 Pt 1):517-8. PubMed ID: 16389719
[No Abstract] [Full Text] [Related]
13. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
Uzun S; Kozumplik O; Jakovljević M; Folnegović-Smalc V
J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
[No Abstract] [Full Text] [Related]
14. Long-acting phenothiazines in schizophrenia.
Freeman H
Lancet; 1972 Dec; 2(7789):1245-6. PubMed ID: 4117727
[No Abstract] [Full Text] [Related]
15. [5 years' experience with prolonged-action neuroleptics].
Lopez-Ibor Aliño JM; Tabares Pujante J
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(5):721-31. PubMed ID: 4150175
[No Abstract] [Full Text] [Related]
16. In brief: Injectable paliperidone palmitate for schizophrenia.
Med Lett Drugs Ther; 2009 Nov; 51(1324):88. PubMed ID: 19890247
[No Abstract] [Full Text] [Related]
17. [Technics for intramuscular injections of delayed-action neuroleptics].
Bélanger-Annable MC
Infirm Can; 1985 Sep; 27(8):26-9. PubMed ID: 2863219
[No Abstract] [Full Text] [Related]
18. Orally disintegrating antipsychotics may promote compliance and adherence in patients with schizophrenia.
Tornatore FL
J Clin Psychiatry; 2005 Nov; 66(11):1493-4; author reply 1494. PubMed ID: 16420093
[No Abstract] [Full Text] [Related]
19. Long-acting neuroleptics: technique for intramuscular injection.
Bélanger-Annable MC
Can Nurse; 1985 Sep; 81(8):41-3. PubMed ID: 2862986
[No Abstract] [Full Text] [Related]
20. The use of depot medications in the treatment of schizophrenia.
Davis JM
Am J Psychiatry; 2010 Feb; 167(2):125-6. PubMed ID: 20123919
[No Abstract] [Full Text] [Related]
[Next] [New Search]